Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 442

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Recommendations for participation in competitive and leisure time sport in athletes with cardiomyopathies, myocarditis, and pericarditis: position statement of the Sport Cardiology Section of the European Association of Preventive Cardiology (EAPC)

Open access
Pelliccia, Antonio, Solberg, Erik Ekker, Papadakis, Michael, Adami, Paolo Emilio, Biffi, Alessandro, Caselli, Stefano, La Gerche, Andrè, Niebauer, Josef, Pressler, Axel, Schmied, Christian M, Serratosa, Luis, Halle, Martin, Van Buuren, Frank, Borjesson, Mats, Carrè, Francois, Panhuyzen-Goedkoop, Nicole M, Heidbuchel, Hein, Olivotto, Iacopo, Corrado, Domenico, Sinagra, Gianfranco, Sharma, Sanjay·2019·European Heart Journal

Abstract

Myocardial diseases are associated with an increased risk of potentially fatal cardiac arrhythmias and sudden cardiac death/cardiac arrest during exercise, including hypertrophic cardiomyopathy, dilated cardiomyopathy, left ventricular non-compaction, arrhythmogenic cardiomyopathy, and myo-pericarditis. Practicing cardiologists and sport physicians are required to identify high-risk individuals harbouring these cardiac diseases in a timely fashion in the setting of preparticipation screening or medical consultation and provide appropriate advice regarding the participation in competitive sport activities and/or regular exercise programmes. Many asymptomatic (or mildly symptomatic) patients with cardiomyopathies aspire to participate in leisure-time and amateur sport activities to take advantage of the multiple benefits of a physically active lifestyle. In 2005, The European Society of Cardiology (ESC) published recommendations for participation in competitive sport in athletes with cardiomyopathies and myo-pericarditis. One decade on, these recommendations are partly obsolete given the evolving knowledge of the diagnosis, management and treatment of cardiomyopathies and myo-pericarditis. The present document, therefore, aims to offer a comprehensive overview of the most updated recommendations for practicing cardiologists and sport physicians managing athletes with cardiomyopathies and myo-pericarditis and provides pragmatic advice for safe participation in competitive sport at professional and amateur level, as well as in a variety of recreational physical activities.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/eurheartj/ehy730

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Research works printed but not linked: 114

  1. Corrado, 2005, Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology, Eur Heart J, 26, 516, 10.1093/eurheartj/ehi108 · DOI · Paper page
  2. Maron, 2007, Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update: a scientific statement from the American Heart Association council on nutrition, physical activity and metabolism. Endorsed by the American College of Cardiology Foundation, Circulation, 115, 1643, 10.1161/CIRCULATIONAHA.107.181423 · DOI · Paper page
  3. Maron, 2015, Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 2: preparticipation screening for cardiovascular disease in competitive athletes, J Am Coll Cardiol, 66, 2356, 10.1016/j.jacc.2015.09.034 · DOI
  4. Pelliccia, 2008, Bethesda Conference #36 and the European Society of Cardiology Consensus Recommendations revisited a comparison of U.S. and European criteria for eligibility and disqualification of competitive athletes with cardiovascular abnormalities, J Am Coll Cardiol, 52, 1990, 10.1016/j.jacc.2008.08.055 · DOI · Paper page
  5. Pelliccia, 2018, European Association of Preventive Cardiology (EAPC) and European Association of Cardiovascular Imaging (EACVI) joint position statement: recommendations for the indication and interpretation of cardiovascular imaging in the evaluation of the athlete's heart, Eur Heart J, 39, 1949, 10.1093/eurheartj/ehx532 · DOI · Paper page
  6. Gersh, 2011, 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, Circulation, 124, e783
  7. Maron, 2009, Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980–2006, Circulation, 119, 1085, 10.1161/CIRCULATIONAHA.108.804617 · DOI · Paper page
  8. Harmon, 2015, Incidence, cause, and comparative frequency of sudden cardiac death in National Collegiate Athletic Association athletes: a decade in review, Circulation, 132, 10, 10.1161/CIRCULATIONAHA.115.015431 · DOI · Paper page
  9. Papadakis, 2011, The prevalence, distribution, and clinical outcomes of electrocardiographic repolarization patterns in male athletes of African/Afro-Caribbean origin, Eur Heart J, 32, 2304, 10.1093/eurheartj/ehr140 · DOI · Paper page
  10. Sheikh, 2015, Clinical profile of athletes with hypertrophic cardiomyopathy, Circ Cardiovasc Imaging, 8, e003454, 10.1161/CIRCIMAGING.114.003454 · DOI · Paper page
  11. Calore, 2015, Clinical meaning of isolated increase of QRS voltages in hypertrophic cardiomyopathy versus athlete's heart, J Electrocardiol, 48, 373, 10.1016/j.jelectrocard.2014.12.016 · DOI
  12. Sheikh, 2018, Diagnostic yield of genetic testing in young athletes with T-wave inversion, Circulation, 138, 1184, 10.1161/CIRCULATIONAHA.118.034208 · DOI
  13. Pelliccia, 2008, Outcomes in athletes with marked ECG repolarization abnormalities, N Engl J Med, 358, 152, 10.1056/NEJMoa060781 · DOI · Paper page
  14. Pelliccia, 1991, The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes, N Engl J Med, 324, 295, 10.1056/NEJM199101313240504 · DOI · Paper page
  15. Basavarajaiah, 2008, Ethnic differences in left ventricular remodeling in highly-trained athletes relevance to differentiating physiologic left ventricular hypertrophy from hypertrophic cardiomyopathy, J Am Coll Cardiol, 51, 2256, 10.1016/j.jacc.2007.12.061 · DOI · Paper page
  16. Caselli, 2014, Differentiating left ventricular hypertrophy in athletes from that in patients with hypertrophic cardiomyopathy, Am J Cardiol, 114, 1383, 10.1016/j.amjcard.2014.07.070 · DOI · Paper page
  17. Basavarajaiah, 2008, Prevalence of hypertrophic cardiomyopathy in highly trained athletes: relevance to pre-participation screening, J Am Coll Cardiol, 51, 1033, 10.1016/j.jacc.2007.10.055 · DOI · Paper page
  18. Rawlins, 2010, Ethnic differences in physiological cardiac adaptation to intense physical exercise in highly trained female athletes, Circulation, 121, 1078, 10.1161/CIRCULATIONAHA.109.917211 · DOI · Paper page
  19. Sheikh, 2013, Cardiac adaptation to exercise in adolescent athletes of African ethnicity: an emergent elite athletic population, Br J Sports Med, 47, 585, 10.1136/bjsports-2012-091874 · DOI
  20. Di Paolo, 2012, The athlete's heart in adolescent Africans: an electrocardiographic and echocardiographic study, J Am Coll Cardiol, 59, 1029, 10.1016/j.jacc.2011.12.008 · DOI
  21. Pelliccia, 1996, Athlete's heart in women. Echocardiographic characterization of highly trained elite female athletes, JAMA, 276, 211, 10.1001/jama.1996.03540030045030 · DOI · Paper page
  22. Finocchiaro, 2018, Role of Doppler diastolic parameters in differentiating physiological left ventricular hypertrophy from hypertrophic cardiomyopathy, J Am Soc Echocardiogr, 31, 606, 10.1016/j.echo.2017.11.022 · DOI
  23. Rickers, 2005, Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy, Circulation, 112, 855, 10.1161/CIRCULATIONAHA.104.507723 · DOI · Paper page
  24. Maron, 2008, Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy, Circ Heart Fail, 1, 184, 10.1161/CIRCHEARTFAILURE.108.768119 · DOI · Paper page
  25. Sharma, 2000, Utility of metabolic exercise testing in distinguishing hypertrophic cardiomyopathy from physiologic left ventricular hypertrophy in athletes, J Am Coll Cardiol, 36, 864, 10.1016/S0735-1097(00)00816-0 · DOI · Paper page
  26. Maron, 1993, Reduction in left ventricular wall thickness after deconditioning in highly trained Olympic athletes, Br Heart J, 69, 125, 10.1136/hrt.69.2.125 · DOI · Paper page
  27. Maron, 2015, Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 3: hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy and other cardiomyopathies, and myocarditis: a scientific statement from the American Heart Association and American College of Cardiology, Circulation, 132, e273
  28. Harmon, 2014, Incidence of sudden cardiac death in athletes: a state-of-the-art review, Br J Sports Med, 48, 1185, 10.1136/bjsports-2014-093872 · DOI · Paper page
  29. Malhotra, 2018, Outcomes of cardiac screening in adolescent soccer players, N Engl J Med, 379, 524, 10.1056/NEJMoa1714719 · DOI · Paper page
  30. Alpert, 2015, Sports and exercise in athletes with hypertrophic cardiomyopathy, Clin Sports Med, 34, 489, 10.1016/j.csm.2015.03.005 · DOI
  31. Maron, 1994, Surviving competitive athletics with hypertrophic cardiomyopathy, Am J Cardiol, 73, 1098, 10.1016/0002-9149(94)90290-9 · doi:10.1016/0002-9149(94)90290-9
  32. Pelliccia, 2018, Does sport participation worsen the clinical course of hypertrophic cardiomyopathy? Clinical outcome of hypertrophic cardiomyopathy in athletes, Circulation, 137, 531, 10.1161/CIRCULATIONAHA.117.031725 · DOI
  33. Spirito, 2014, Risk of sudden death and outcome in patients with hypertrophic cardiomyopathy with benign presentation and without risk factors, Am J Cardiol, 113, 1550, 10.1016/j.amjcard.2014.01.435 · DOI
  34. Ho, 2010, Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy, N Engl J Med, 363, 552, 10.1056/NEJMoa1002659 · DOI · Paper page
  35. Ho, 2013, T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy, Circ Cardiovasc Imaging, 6, 415, 10.1161/CIRCIMAGING.112.000333 · DOI · Paper page
  36. Ho, 2002, Assessment of diastolic function with Doppler tissue imaging to predict genotype in preclinical hypertrophic cardiomyopathy, Circulation, 105, 2992, 10.1161/01.CIR.0000019070.70491.6D · DOI · Paper page
  37. Gray, 2011, Natural history of genotype positive-phenotype negative patients with hypertrophic cardiomyopathy, Int J Cardiol, 152, 258, 10.1016/j.ijcard.2011.07.095 · DOI
  38. Jensen, 2013, Penetrance of hypertrophic cardiomyopathy in children and adolescents: a 12-year follow-up study of clinical screening and predictive genetic testing, Circulation, 127, 48, 10.1161/CIRCULATIONAHA.111.090514 · DOI
  39. Vermeer, 2017, Penetrance of hypertrophic cardiomyopathy in children who are mutation positive, J Pediatr, 188, 91, 10.1016/j.jpeds.2017.03.033 · DOI
  40. Caselli, 2018, The electrocardiogram and the phenotypic expression of hypertrophic cardiomyopathy, Eur Heart J
  41. Pinto, 2016, Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases, Eur Heart J, 37, 1850, 10.1093/eurheartj/ehv727 · DOI · Paper page
  42. Rapezzi, 2013, Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial Diseases, Eur Heart J, 34, 1448, 10.1093/eurheartj/ehs397 · DOI · Paper page
  43. Gavazzi, 1993, The spectrum of left ventricular size in dilated cardiomyopathy: clinical correlates and prognostic implications. SPIC (Italian Multicenter Cardiomyopathy Study) Group, Am Heart J, 125, 410, 10.1016/0002-8703(93)90020-A · DOI
  44. Pelliccia, 1999, Physiologic left ventricular cavity dilatation in elite athletes, Ann Intern Med, 130, 23, 10.7326/0003-4819-130-1-199901050-00005 · DOI · Paper page
  45. Finocchiaro, 2017, Effect of sex and sporting discipline on LV adaptation to exercise, JACC Cardiovasc Imaging, 10, 965, 10.1016/j.jcmg.2016.08.011 · DOI · Paper page
  46. Abergel, 2004, Serial left ventricular adaptations in world-class professional cyclists: implications for disease screening and follow-up, J Am Coll Cardiol, 44, 144, 10.1016/j.jacc.2004.02.057 · DOI · Paper page
  47. Millar, 2016, Exercise echocardiography has a high sensitivity and specificity in differentiating athlete’s heart from dilated cardiomyopathy, Circulation, 134, A15662
  48. Claessen, 2018, Exercise cardiac magnetic resonance to differentiate athlete's heart from structural heart disease, Eur Heart J Cardiovasc Imaging, 19, 1062, 10.1093/ehjci/jey050 · DOI
  49. Gulati, 2013, Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy, JAMA, 309, 896, 10.1001/jama.2013.1363 · DOI · Paper page
  50. Halliday, 2017, Association between midwall late gadolinium enhancement and sudden cardiac death in patients with dilated cardiomyopathy and mild and moderate left ventricular systolic dysfunction, Circulation, 135, 2106, 10.1161/CIRCULATIONAHA.116.026910 · DOI · Paper page
  51. Spezzacatene, 2015, . Arrhythmogenic phenotype in dilated cardiomyopathy: natural history and predictors of life-threatening arrhythmias, J Am Heart Assoc, 4, e002149, 10.1161/JAHA.115.002149 · DOI
  52. van Rijsingen, 2012, Risk factors for malignant ventricular arrhythmias in lamin a/c mutation carriers a European cohort study, J Am Coll Cardiol, 59, 493, 10.1016/j.jacc.2011.08.078 · DOI · Paper page
  53. Webb-Peploe, 2000, Different response of patients with idiopathic and ischaemic dilated cardiomyopathy to exercise training, Int J Cardiol, 74, 215, 10.1016/S0167-5273(00)00293-X · DOI
  54. Haykowsky, 2013, Meta-analysis of aerobic interval training on exercise capacity and systolic function in patients with heart failure and reduced ejection fractions, Am J Cardiol, 111, 1466, 10.1016/j.amjcard.2013.01.303 · DOI · Paper page
  55. Hershberger, 2013, Dilated cardiomyopathy: the complexity of a diverse genetic architecture, Nat Rev Cardiol, 10, 531, 10.1038/nrcardio.2013.105 · DOI · Paper page
  56. Towbin, 2015, Left ventricular non-compaction cardiomyopathy, Lancet, 386, 813, 10.1016/S0140-6736(14)61282-4 · DOI · Paper page
  57. Steffel, 2009, Electrocardiographic characteristics at initial diagnosis in patients with isolated left ventricular noncompaction, Am J Cardiol, 104, 984, 10.1016/j.amjcard.2009.05.042 · DOI
  58. Jenni, 2001, Echocardiographic and pathoanatomical characteristics of isolated left ventricular non-compaction: a step towards classification as a distinct cardiomyopathy, Heart, 86, 666, 10.1136/heart.86.6.666 · DOI · Paper page
  59. Chin, 1990, Isolated noncompaction of left ventricular myocardium. A study of eight cases, Circulation, 82, 507, 10.1161/01.CIR.82.2.507 · DOI · Paper page
  60. Gebhard, 2012, Reduced left ventricular compacta thickness: a novel echocardiographic criterion for non-compaction cardiomyopathy, J Am Soc Echocardiogr, 25, 1050, 10.1016/j.echo.2012.07.003 · doi:10.1016/j.echo.2012.07.003
  61. Gati, 2013, Increased left ventricular trabeculation in highly trained athletes: do we need more stringent criteria for the diagnosis of left ventricular non-compaction in athletes?, Heart, 99, 401, 10.1136/heartjnl-2012-303418 · DOI · Paper page
  62. Gati, 2014, Reversible de novo left ventricular trabeculations in pregnant women: implications for the diagnosis of left ventricular noncompaction in low-risk populations, Circulation, 130, 475, 10.1161/CIRCULATIONAHA.114.008554 · DOI · Paper page
  63. Caselli, 2015, Left ventricular noncompaction diagnosis and management relevant to pre-participation screening of athletes, Am J Cardiol, 116, 801, 10.1016/j.amjcard.2015.05.055 · DOI
  64. Caselli, 2016, Prominent left ventricular trabeculations in competitive athletes: a proposal for risk stratification and management, Int J Cardiol, 223, 590, 10.1016/j.ijcard.2016.08.272 · DOI
  65. Petersen, 2005, Left ventricular non-compaction: insights from cardiovascular magnetic resonance imaging, J Am Coll Cardiol, 46, 101, 10.1016/j.jacc.2005.03.045 · DOI · Paper page
  66. Zemrak, 2014, The relationship of left ventricular trabeculation to ventricular function and structure over a 9.5-year follow-up: the MESA study, J Am Coll Cardiol, 64, 1971, 10.1016/j.jacc.2014.08.035 · DOI · Paper page
  67. Corrado, 2017, Arrhythmogenic right ventricular cardiomyopathy, N Engl J Med, 376, 61, 10.1056/NEJMra1509267 · DOI · Paper page
  68. Thiene, 1988, Right ventricular cardiomyopathy and sudden death in young people, N Engl J Med, 318, 129, 10.1056/NEJM198801213180301 · DOI · Paper page
  69. Bagnall, 2016, A prospective study of sudden cardiac death among children and young adults, N Engl J Med, 374, 2441, 10.1056/NEJMoa1510687 · DOI · Paper page
  70. Marcus, 2010, Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria, Circulation, 121, 1533, 10.1161/CIRCULATIONAHA.108.840827 · DOI · Paper page
  71. Nasir, 2004, Electrocardiographic features of arrhythmogenic right ventricular dysplasia/cardiomyopathy according to disease severity: a need to broaden diagnostic criteria, Circulation, 110, 1527, 10.1161/01.CIR.0000142293.60725.18 · DOI · Paper page
  72. Bauce, 2010, Differences and similarities between arrhythmogenic right ventricular cardiomyopathy and athlete's heart adaptations, Br J Sports Med, 44, 148, 10.1136/bjsm.2007.042853 · DOI
  73. Perazzolo Marra, 2015, Arrhythmogenic right ventricular cardiomyopathy. Contribution of cardiac magnetic resonance imaging to the diagnosis, Herz, 40, 600, 10.1007/s00059-015-4228-0 · DOI
  74. Zaidi, 2013, Physiological right ventricular adaptation in elite athletes of African and Afro-Caribbean origin, Circulation, 127, 1783, 10.1161/CIRCULATIONAHA.112.000270 · DOI
  75. D'Ascenzi, 2017, RV remodeling in olympic athletes, JACC Cardiovasc Imaging, 10, 385, 10.1016/j.jcmg.2016.03.017 · DOI
  76. Quarta, 2011, Familial evaluation in arrhythmogenic right ventricular cardiomyopathy: impact of genetics and revised Task Force Criteria, Circulation, 123, 2701, 10.1161/CIRCULATIONAHA.110.976936 · DOI · Paper page
  77. Kapplinger, 2011, Distinguishing arrhythmogenic right ventricular cardiomyopathy/dysplasia-associated mutations from background genetic noise, J Am Coll Cardiol, 57, 2317, 10.1016/j.jacc.2010.12.036 · DOI · Paper page
  78. Calkins, 2017, Risk stratification in arrhythmogenic right ventricular cardiomyopathy, Circulation, 136, 2068, 10.1161/CIRCULATIONAHA.117.030792 · DOI · Paper page
  79. Maupain, 2018, Risk stratification in arrhythmogenic right ventricular cardiomyopathy/dysplasia without an implantable cardioverter-defibrillator, JACC Clin Electrophysiol, 4, 757, 10.1016/j.jacep.2018.04.017 · DOI
  80. Kirchhof, 2006, Age- and training-dependent development of arrhythmogenic right ventricular cardiomyopathy in heterozygous plakoglobin-deficient mice, Circulation, 114, 1799, 10.1161/CIRCULATIONAHA.106.624502 · DOI · Paper page
  81. James, 2013, Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers, J Am Coll Cardiol, 62, 1290, 10.1016/j.jacc.2013.06.033 · DOI · Paper page
  82. Saberniak, 2014, Vigorous physical activity impairs myocardial function in patients with arrhythmogenic right ventricular cardiomyopathy and in mutation positive family members, Eur J Heart Fail, 16, 1337, 10.1002/ejhf.181 · DOI · Paper page
  83. Ruwald, 2015, Association of competitive and recreational sport participation with cardiac events in patients with arrhythmogenic right ventricular cardiomyopathy: results from the North American multidisciplinary study of arrhythmogenic right ventricular cardiomyopathy, Eur Heart J, 36, 1735, 10.1093/eurheartj/ehv110 · DOI · Paper page
  84. Sawant, 2014, Exercise has a disproportionate role in the pathogenesis of arrhythmogenic right ventricular dysplasia/cardiomyopathy in patients without desmosomal mutations, J Am Heart Assoc, 3, e001471, 10.1161/JAHA.114.001471 · DOI · Paper page
  85. La Gerche, 2010, Lower than expected desmosomal gene mutation prevalence in endurance athletes with complex ventricular arrhythmias of right ventricular origin, Heart, 96, 1268, 10.1136/hrt.2009.189621 · DOI · Paper page
  86. Schnell, 2015, Recognition and significance of pathological T-wave inversions in athletes, Circulation, 131, 165, 10.1161/CIRCULATIONAHA.114.011038 · DOI
  87. Sharma, 2017, International recommendations for electrocardiographic interpretation in athletes, J Am Coll Cardiol, 69, 1057, 10.1016/j.jacc.2017.01.015 · DOI · Paper page
  88. Lampert, 2017, Safety of sports for athletes with implantable cardioverter-defibrillators: long-term results of a prospective multinational registry, Circulation, 135, 2310, 10.1161/CIRCULATIONAHA.117.027828 · DOI
  89. Heidbuchel, 2007, Implantable cardioverter defibrillator therapy in athletes, Cardiol Clin, 25, 467, 10.1016/j.ccl.2007.07.004 · DOI
  90. Heidbuchel, 2014, Exercise and competitive sports in patients with an implantable cardioverter-defibrillator, Eur Heart J, 35, 3097, 10.1093/eurheartj/ehu130 · DOI
  91. Heidbuchel, 2006, Recommendations for participation in leisure-time physical activity and competitive sports of patients with arrhythmias and potentially arrhythmogenic conditions Part II: ventricular arrhythmias, channelopathies and implantable defibrillators, Eur J Cardiovasc Prev Rehabil, 13, 676, 10.1097/01.hjr.0000239465.26132.29 · DOI · Paper page
  92. Pelliccia, 2013, Leisure-time physical activity and sport participation in patients with Cardiomyopathies, Card Electrophysiol Clin, 5, 65, 10.1016/j.ccep.2012.11.005 · DOI
  93. Saberi, 2017, Effect of moderate-intensity exercise training on peak oxygen consumption in patients with hypertrophic cardiomyopathy: a randomized clinical trial, JAMA, 317, 1349, 10.1001/jama.2017.2503 · DOI · Paper page
  94. Klempfner, 2015, Efficacy of exercise training in sympomatic patients with hypertrophic cardiomyopathy: results of a structured exercise training program in a cardiac rehabilitation center, Eur J Prev Cardiol, 22, 13, 10.1177/2047487313501277 · DOI
  95. Olivotto, 2013, Obesity and its association to phenotype and clinical course in hypertrophic cardiomyopathy, J Am Coll Cardiol, 62, 449, 10.1016/j.jacc.2013.03.062 · DOI · Paper page
  96. Sinagra, 2016, Myocarditis in Clinical Practice, Mayo Clin Proc, 91, 1256, 10.1016/j.mayocp.2016.05.013 · DOI · Paper page
  97. Caforio, 2013, Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases, Eur Heart J, 34, 2636, 10.1093/eurheartj/eht210 · DOI · Paper page
  98. Morgera, 1992, Electrocardiography of myocarditis revisited: clinical and prognostic significance of electrocardiographic changes, Am Heart J, 124, 455, 10.1016/0002-8703(92)90613-Z · DOI · Paper page
  99. Pinamonti, 1988, Echocardiographic findings in myocarditis, Am J Cardiol, 62, 285, 10.1016/0002-9149(88)90226-3 · DOI · Paper page
  100. Caforio, 2007, A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis, Eur Heart J, 28, 1326, 10.1093/eurheartj/ehm076 · DOI · Paper page
  101. Friedrich, 2009, Cardiovascular magnetic resonance in myocarditis: a JACC White Paper, J Am Coll Cardiol, 53, 1475, 10.1016/j.jacc.2009.02.007 · DOI · Paper page
  102. Schnell, 2016, Subepicardial delayed gadolinium enhancement in asymptomatic athletes: let sleeping dogs lie?, Br J Sports Med, 50, 111, 10.1136/bjsports-2014-094546 · DOI
  103. Mewton, 2015, Myocardial biomarkers and delayed enhanced cardiac magnetic resonance relationship in clinically suspected myocarditis and insight on clinical outcome, J Cardiovasc Med (Hagerstown), 16, 696, 10.2459/JCM.0000000000000024 · DOI
  104. van de Schoor, 2016, Myocardial fibrosis in athletes, Mayo Clin Proc, 91, 1617, 10.1016/j.mayocp.2016.07.012 · DOI · Paper page
  105. Schumm, 2014, Cardiovascular magnetic resonance risk stratification in patients with clinically suspected myocarditis, J Cardiovasc Magn Reson, 16, 14., 10.1186/1532-429X-16-14 · DOI
  106. Grün, 2012, Long-term follow-up of biopsy-proven viral myocarditis: predictors of mortality and incomplete recovery, J Am Coll Cardiol, 59, 1604, 10.1016/j.jacc.2012.01.007 · DOI · Paper page
  107. Cooper, 2008, Usefulness of immunosuppression for giant cell myocarditis, Am J Cardiol, 102, 1535, 10.1016/j.amjcard.2008.07.041 · DOI · Paper page
  108. Kiel, 1989, Coxsackievirus B3 myocarditis in C3H/HeJ mice: description of an inbred model and the effect of exercise on virulence, Eur J Epidemiol, 5, 348, 10.1007/BF00144836 · DOI
  109. Phillips, 1986, Sudden cardiac death in Air Force recruits: a 20-year review, JAMA, 256, 2696, 10.1001/jama.1986.03380190066026 · doi:10.1001/jama.1986.03380190066026 · Paper page
  110. Bohm, 2016, Data from a nationwide registry on sports-related sudden cardiac deaths in Germany, Eur J Prev Cardiol, 23, 649, 10.1177/2047487315594087 · DOI · Paper page
  111. Anzini, 2013, Long-term evolution and prognostic stratification of biopsy-proven active myocarditis, Circulation, 128, 2384, 10.1161/CIRCULATIONAHA.113.003092 · DOI · Paper page
  112. Magnani, 2006, Survival in biopsy-proven myocarditis: a long-term retrospective analysis of the histopathologic, clinical, and hemodynamic predictors, Am Heart J, 151, 463, 10.1016/j.ahj.2005.03.037 · DOI · Paper page
  113. Imazio, 2015, Evaluation and treatment of pericarditis: a systematic review, JAMA, 314, 1498, 10.1001/jama.2015.12763 · DOI · Paper page
  114. Imazio, 2010, Controversial issues in the management of pericardial diseases, Circulation, 121, 916, 10.1161/CIRCULATIONAHA.108.844753 · DOI · Paper page

Cited by

See all 442

Metadata

Authors
Pelliccia, A., Solberg, E. E., Papadakis, M., Adami, P. E., Biffi, A., Caselli, S., La Gerche, A., Niebauer, J., Pressler, A., Schmied, C. M., Serratosa, L., Halle, M., Van Buuren, F., Borjesson, M., Carrè, F., Panhuyzen-Goedkoop, N. M., Heidbuchel, H., Olivotto, I., Corrado, D., Sinagra, G., & Sharma, S.
Venue
European Heart Journal
Published
2018-12-14
Volume
40
Issue
1
Pages
19-33
ISSN
  • 0195-668X (ISSN-L)
  • 1522-9645
OpenAlex
W2903720062
Cited by
442
References
8
FWCI
35.10
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Recommendations for participation in competitive and leisure time sport in athletes with cardiomyopathies, myocarditis, and pericarditis: position statement of the Sport Cardiology Section of the European Association of Preventive Cardiology (EAPC). https://app.cochat.ai/papers/10.1093/eurheartj/ehy730
The paper
Pelliccia, A., Solberg, E. E., Papadakis, M., Adami, P. E., Biffi, A., Caselli, S., La Gerche, A., Niebauer, J., Pressler, A., Schmied, C. M., Serratosa, L., Halle, M., Van Buuren, F., Borjesson, M., Carrè, F., Panhuyzen-Goedkoop, N. M., Heidbuchel, H., Olivotto, I., Corrado, D., . . . Sharma, S. (2019). Recommendations for participation in competitive and leisure time sport in athletes with cardiomyopathies, myocarditis, and pericarditis: position statement of the Sport Cardiology Section of the European Association of Preventive Cardiology (EAPC). European Heart Journal. https://doi.org/10.1093/eurheartj/ehy730

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.